ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from Agilent Technologies | LabRulez ICPMS

    Proven Solutions for Clinical Research Applications - Agilent clinical research solutions

    Brochures and specifications
    | 2018 | Agilent Technologies
    GC/MSD, GC/MS/MS, GC/HRMS, Sample Preparation, GC/TOF, Consumables, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns, LC/QQQ, ICP/MS, ICP/MS/MS
    Instrumentation
    GC/MSD, GC/MS/MS, GC/HRMS, Sample Preparation, GC/TOF, Consumables, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns, LC/QQQ, ICP/MS, ICP/MS/MS
    Manufacturer
    Agilent Technologies
    Industries
    Clinical Research

    Support for 21 CFR Part 11 and Annex 11 Compliance: SDA Module for Agilent ICP-MS MassHunter Software

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS, ICP/MS/MS
    Instrumentation
    Software, ICP/MS, ICP/MS/MS
    Manufacturer
    Agilent Technologies
    Industries

    Sensitive, high-throughput analysis of lead in whole blood using the Agilent 7500cx ICP-MS with ISIS-DS

    Applications
    | 2015 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Clinical Research

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Server or ECM XT

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Sanofi-aventis - A high throughput assay for oxaliplatin in clinical samples

    Others
    | 2007 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Trust Proven MS/MS Technology

    Others
    | 2018 | Agilent Technologies
    ICP/MS, ICP/MS/MS
    Instrumentation
    ICP/MS, ICP/MS/MS
    Manufacturer
    Agilent Technologies
    Industries

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma

    Technical notes
    | 2016 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent MicroLab Pharma

    Technical notes
    | 2020 | Agilent Technologies
    Software, FTIR Spectroscopy
    Instrumentation
    Software, FTIR Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent SpectrAA CFR software

    Technical notes
    | 2020 | Agilent Technologies
    Software, AAS
    Instrumentation
    Software, AAS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent ICP Expert 21 CFR Part 11 software

    Technical notes
    | 2020 | Agilent Technologies
    Software, ICP/OES
    Instrumentation
    Software, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma
     

    Related content


    Advances in Chromatography and Electrophoresis & Chiranal 2024 (Programme)

    Mo, 13.5.2024
    Advances in Chromatography and Electrophoresis & Chiranal

    Mother’s protein intake during pregnancy can affect newborn’s facial development

    Su, 12.5.2024
    CEITEC

    Material genetics will be pursued by the AMULET project, which succeeded in the Excellent Research Call

    Th, 9.5.2024
    Ústav organické chemie a biochemie AV ČR
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike